This study aimed to investigate the predictive value of NID2 by analyzing the glioma clinical datasets, including GSE16011, GSE7696, GSE4290, the Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA), and a glioma tissue microarray (TMA). Here, NID2 is linked to cancer.